1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Primary pulmonary angiosarcoma mimicking diffuse pulmonary hemorrhage: A case report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary angiosarcomas are usually secondary tumors, and a primary angiosarcoma of the lung is extremely rare. The present study reports a case of an elderly patient diagnosed with primary pulmonary angiosarcoma (PPA). A 78-year-old man presented with a 3-month history of cough and blood in phlegm. A computed tomography scan of the chest indicated pulmonary infection with ground-glass opacity in the right upper lobe. The patient underwent lobectomy of the right upper lobe as his clinical symptoms did not significantly improve after anti-infection treatment. The postoperative pathological examination confirmed a diagnosis of PPA. He developed left lung and pelvic metastases 1 month after surgery. After four cycles of liposomal doxorubicin therapy, the patient achieved partial remission. The patient remained in sustained remission after 6 months of follow-up. The present case report is intended to provide diagnostic insight into PPA. In addition, the findings indicate that timely diagnosis and treatment of PPA are very important due to its increased risk of local recurrence and distant metastasis.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Angiosarcoma.

          Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly presenting as cutaneous disease in elderly white men, involving the head and neck and particularly the scalp. They can be caused by therapeutic radiation or chronic lymphoedema and hence secondary breast angiosarcomas are an important subgroup. Recent work has sought to establish the molecular biology of angiosarcomas and identify specific targets for treatment. Interest is now focused on trials of vascular-targeted drugs, which are showing promise in the control of angiosarcomas. In this review we discuss angiosarcoma and its current management, with a focus on clinical trials investigating the treatment of advanced disease. Copyright © 2010 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.

            Recent data suggest that patients with pulmonary metastases from sarcomas might benefit from ablation of their metastases. Some data are available regarding osteosarcomas/angiosarcomas and lung metastases. The purpose of this study was to assess the efficacy of local ablative treatment on the survival of patients with oligometastases (one to five lesions, any metastatic site, any grade/histology) from sarcomas.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Complete radiographic response of primary pulmonary angiosarcomas following gemcitabine and taxotere.

              A small number of patients with angiosarcoma present each year, even fewer of whom have their primary origin site in the lungs. As such, specific treatments are not well defined for this tumor type. We report that the combination of gemcitabine and docetaxel may be an effective regimen for the treatment of angiosarcoma, as illustrated by the complete radiological response observed. In this case report, we review the clinical characteristics, prevalence and treatment options for angiosarcoma. In particular, we review the potential pitfalls and important attributes that should inform diagnosis.
                Bookmark

                Author and article information

                Journal
                Oncol Lett
                Oncol Lett
                OL
                Oncology Letters
                D.A. Spandidos
                1792-1074
                1792-1082
                May 2023
                06 April 2023
                06 April 2023
                : 25
                : 5
                : 211
                Affiliations
                [1 ]Department of Gastroenterology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China
                [2 ]Department of Pathology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China
                [3 ]Department of Oncology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China
                Author notes
                Correspondence to: Dr Dongdong Zhang, Department of Oncology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, 15 Jiefang Road, Xiangyang, Hubei 441000, P.R. China, E-mail: drwenbingao163.com zhangdongdong@ 123456whu.edu.cn
                Article
                OL-25-5-13797
                10.3892/ol.2023.13797
                10131260
                37123023
                598095d5-8ae3-4edf-bed5-4c76b62d5d6a
                Copyright: © Lin et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

                History
                : 04 January 2023
                : 09 March 2023
                Funding
                Funded by: Innovative Research Program of Xiangyang No. 1 People's Hospital
                Award ID: XYY2021Q02
                Funded by: Platform Special Fund for Scientific Research of Xiangyang No. 1 People's Hospital
                Award ID: XYY2022P05
                Funded by: Key Projects of Xiangyang Science and Technology Bureau
                Award ID: 2021YL26
                This study was supported by the Innovative Research Program of Xiangyang No. 1 People's Hospital (grant no. XYY2021Q02), the Platform Special Fund for Scientific Research of Xiangyang No. 1 People's Hospital (grant no. XYY2022P05) and the Key Projects of Xiangyang Science and Technology Bureau (grant no. 2021YL26).
                Categories
                Articles

                Oncology & Radiotherapy
                angiosarcoma,primary pulmonary epithelioid angiosarcoma,pulmonary injection

                Comments

                Comment on this article